Skip to content
Back to media centre

nib responds to ACCC

nib holdings (nib) has been advised by the Australian Competition and Consumer Commission (ACCC) that it intends to institute proceedings in the Federal Court against nib's Australian residents health fund primarily in relation to an alleged failure in August 2015 to communicate to customers limited changes made to its MediGap Scheme.

MediGap is a scheme in which doctors and other in-hospital medical providers can elect to receive a higher level of fee reimbursement subject to there being no "out of pocket" expense for the patient.

nib rejects the position being taken by the ACCC and believes it has acted lawfully and ethically. nib has worked collaboratively with the ACCC throughout its investigation and has already taken steps to redress many ACCC concerns.

nib is committed to acting in the best interests of our customers and will strenuously defend the claims made by the ACCC in the Federal Court. One of the objectives behind the limited changes made to MediGap was principally about improved clinical practice. As this matter is now before the Federal Court, we are unable to make any further comment on the allegations.

Apr 07, 2025

nib Travel reveals seasonal travel trends

couple hugging on beach
Apr 03, 2025

nib foundation funds local research

woman in lab
Mar 31, 2025

nib Group launches third Reconciliation Action Plan

RAP image
Artwork by Michelle Kerrin